RYTM Q1 2021 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RYTMRhythm Pharmaceuticals, Inc.

$6B

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35,000

Gross Profit

$31,00088.6% margin

Operating Income

-$34M-98280.0% margin

Net Income

$44M125000.0% margin

EPS (Diluted)

$0.90

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$34M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$422M

Total Liabilities

$41M

Stockholders' Equity

$381M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35,000	$0	—
Gross Profit	$31,000	$0	—
Operating Income	-$34M	-$35M	+2.6%
Net Income	$44M	-$34M	+228.1%